<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Recurring Abnormalities | Clinical Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Recurring Cytogenetic Abnormalities in Hematologic Malignancies  Definition: Recurring cytogenetic abnormalities are specific chromosomal changes (translocations, deletions,...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Recurring Abnormalities | Clinical Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Recurring Cytogenetic Abnormalities in Hematologic Malignancies  Definition: Recurring cytogenetic abnormalities are specific chromosomal changes (translocations, deletions,...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Recurring Abnormalities | Clinical Hematology">
<meta name="twitter:description" content="Overview of Recurring Cytogenetic Abnormalities in Hematologic Malignancies  Definition: Recurring cytogenetic abnormalities are specific chromosomal changes (translocations, deletions,...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><!-- Google tag (gtag.js) --><script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Clinical Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="active" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="recurring-abnormalities" class="section level1 unnumbered">
<h1>Recurring Abnormalities<a class="anchor" aria-label="anchor" href="#recurring-abnormalities"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-recurring-cytogenetic-abnormalities-in-hematologic-malignancies" class="section level2 unnumbered">
<h2>
<strong>Overview of Recurring Cytogenetic Abnormalities in Hematologic Malignancies</strong><a class="anchor" aria-label="anchor" href="#overview-of-recurring-cytogenetic-abnormalities-in-hematologic-malignancies"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> Recurring cytogenetic abnormalities are specific chromosomal changes (translocations, deletions, inversions, etc.) that are frequently observed in certain types of hematologic malignancies</li>
<li>
<strong>Importance in WHO Classification:</strong>
<ul>
<li>Diagnostic: The presence of certain recurring cytogenetic abnormalities is used as a defining criterion for specific subtypes of leukemia, lymphoma, and myeloproliferative neoplasms in the WHO classification</li>
<li>Prognostic: Many recurring cytogenetic abnormalities have prognostic significance, meaning they can help predict the likely outcome of the disease</li>
<li>Therapeutic: Some genetic abnormalities are targets for specific therapies</li>
</ul>
</li>
<li>
<strong>Testing Methods:</strong>
<ul>
<li>Cytogenetic Analysis (Karyotyping): Traditional method for identifying chromosomal abnormalities</li>
<li>Fluorescence In Situ Hybridization (FISH): Used to detect specific chromosomal abnormalities more rapidly and sensitively</li>
<li>Molecular Testing (PCR, NGS): Can detect gene mutations and fusion genes that result from chromosomal rearrangements</li>
</ul>
</li>
</ul>
</div>
<div id="recurring-cytogenetic-abnormalities-by-who-classification" class="section level2 unnumbered">
<h2>
<strong>Recurring Cytogenetic Abnormalities by WHO Classification</strong><a class="anchor" aria-label="anchor" href="#recurring-cytogenetic-abnormalities-by-who-classification"><i class="fas fa-link"></i></a>
</h2>
<p>Here, we’ll break down the key cytogenetic abnormalities associated with different types of myeloid and lymphoid neoplasms according to the WHO classification. Please note that the WHO classification is updated periodically, so it’s important to consult the most recent version for the most current information.</p>
</div>
<div id="myeloid-neoplasms" class="section level2 unnumbered">
<h2>
<strong>Myeloid Neoplasms</strong><a class="anchor" aria-label="anchor" href="#myeloid-neoplasms"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities</strong></p>
<ul>
<li>t(8;21)(q22;q22.1); <em>RUNX1-RUNX1T1</em> (AML1-ETO):
<ul>
<li>Favorable prognosis</li>
<li>Morphology: AML with maturation, often showing Auer rods</li>
<li>Immunophenotype: Expresses myeloid markers (CD13, CD33, CD117), often co-expresses CD19</li>
</ul>
</li>
<li>inv(16)(p13.1q22) or t(16;16)(p13.1;q22); <em>CBFB-MYH11:</em>
<ul>
<li>Favorable prognosis</li>
<li>Morphology: AML with abnormal eosinophils in the bone marrow</li>
<li>Immunophenotype: Expresses myeloid markers, CD11b, and CD2; eosinophil markers</li>
</ul>
</li>
<li>t(15;17)(q24.1;q21.1); <em>PML-RARA</em> (Acute Promyelocytic Leukemia - APL):
<ul>
<li>Favorable prognosis with appropriate treatment</li>
<li>Morphology: Abnormal promyelocytes with Auer rods</li>
<li>Clinical Significance: Associated with disseminated intravascular coagulation (DIC)</li>
<li>Treatment: All-trans retinoic acid (ATRA) and arsenic trioxide (ATO)</li>
</ul>
</li>
<li>t(9;11)(p21.3;q23.3); <em>MLLT3-KMT2A:</em>
<ul>
<li>Poor prognosis</li>
<li>Morphology: Acute monocytic leukemia or acute myelomonocytic leukemia</li>
<li>Immunophenotype: Expresses monocytic markers (CD14, CD11b, CD4, CD36, CD64)</li>
</ul>
</li>
<li>inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); <em>GATA2, MECOM</em> (EVI1):
<ul>
<li>Unfavorable prognosis</li>
<li>Associated with increased blasts and multi-lineage dysplasia</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Myelodysplastic Syndromes (MDS)</strong></p>
<ul>
<li>del(5q):
<ul>
<li>MDS with Isolated del(5q):
<ul>
<li>Anemia</li>
<li>Normal or elevated platelet count</li>
<li>Hypolobated megakaryocytes in the bone marrow</li>
<li>Good response to lenalidomide</li>
</ul>
</li>
</ul>
</li>
<li>Trisomy 8 (+8):
<ul>
<li>Common in MDS and AML</li>
<li>May be associated with dysplasia in multiple cell lines</li>
<li>Variable prognosis</li>
</ul>
</li>
<li>del(20q):
<ul>
<li>Often associated with isolated anemia and a relatively indolent course</li>
</ul>
</li>
<li>del(7q) or Monosomy 7 (-7):
<ul>
<li>Associated with poor prognosis and a high risk of transformation to AML</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Myeloproliferative Neoplasms (MPNs)</strong></p>
<ul>
<li>t(9;22)(q34.1;q11.2); <em>BCR-ABL1</em> (Chronic Myeloid Leukemia - CML):
<ul>
<li>Diagnostic hallmark of CML</li>
<li>Results in a fusion protein with constitutive tyrosine kinase activity</li>
</ul>
</li>
<li>
<em>JAK2</em> V617F Mutation:
<ul>
<li>Present in &gt;95% of Polycythemia Vera (PV) cases and in approximately 50-60% of Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF) cases</li>
<li>A gain-of-function mutation that activates the JAK-STAT signaling pathway</li>
</ul>
</li>
<li>
<em>CALR</em> Mutations:
<ul>
<li>Mutations in the calreticulin (<em>CALR</em>) gene are found in approximately 25% of ET and PMF cases that are <em>JAK2</em>-negative</li>
<li>Involve insertions or deletions in exon 9 of <em>CALR</em>, leading to a frameshift and altered protein function</li>
</ul>
</li>
<li>
<em>MPL</em> Mutations:
<ul>
<li>Mutations in the thrombopoietin receptor gene (<em>MPL</em>) are found in approximately 5-10% of ET and PMF cases that are <em>JAK2</em>-negative and <em>CALR</em>-negative</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="lymphoid-neoplasms" class="section level2 unnumbered">
<h2>
<strong>Lymphoid Neoplasms</strong><a class="anchor" aria-label="anchor" href="#lymphoid-neoplasms"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Precursor B-Cell Neoplasms (B-Lymphoblastic Leukemia/Lymphoma):</strong></p>
<ul>
<li>t(9;22)(q34.1;q11.2); <em>BCR-ABL1</em>:
<ul>
<li>Seen in ~25% of adult B-ALL cases</li>
<li>Associated with poor prognosis</li>
</ul>
</li>
<li>t(12;21)(p13.2;q22.1); <em>ETV6-RUNX1</em>:
<ul>
<li>Most common translocation in childhood B-ALL</li>
<li>Associated with favorable prognosis</li>
</ul>
</li>
<li>t(v;11q23.3); <em>KMT2A</em> (MLL) rearranged:
<ul>
<li>Seen in infants and adults with B-ALL</li>
<li>Associated with poor prognosis</li>
</ul>
</li>
<li>t(1;19)(q23;p13.3); <em>TCF3-PBX1:</em>
<ul>
<li>Seen in ~25% of childhood B-ALL cases</li>
<li>Associated with increased risk of relapse</li>
<li>Hyperdiploidy:
<ul>
<li>Gain of multiple chromosomes (more than 50 chromosomes)</li>
<li>Associated with favorable prognosis in childhood B-ALL</li>
</ul>
</li>
</ul>
</li>
<li>Hypodiploidy:
<ul>
<li>Loss of multiple chromosomes (less than 46 chromosomes)</li>
<li>Associated with poor prognosis in childhood B-ALL</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Mature B-Cell Neoplasms:</strong></p>
<ul>
<li>t(14;18)(q32;q21); <em>IGH-BCL2</em> (Follicular Lymphoma):
<ul>
<li>Diagnostic hallmark of follicular lymphoma</li>
<li>Results in overexpression of BCL2, an anti-apoptotic protein</li>
</ul>
</li>
<li>t(11;14)(q13;q32); <em>CCND1-IGH</em> (Mantle Cell Lymphoma):
<ul>
<li>Diagnostic hallmark of mantle cell lymphoma</li>
<li>Results in overexpression of cyclin D1, a cell cycle regulator</li>
</ul>
</li>
<li>t(8;14)(q24;q32); <em>MYC-IGH</em> (Burkitt Lymphoma):
<ul>
<li>Diagnostic hallmark of Burkitt lymphoma</li>
<li>Results in overexpression of MYC, a transcription factor that promotes cell growth</li>
</ul>
</li>
<li>del(13q14.3) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma):
*Good Prognosis</li>
</ul>
</li>
</ul>
</div>
<div id="molecular-testing-pcr-and-ngs" class="section level2 unnumbered">
<h2>
<strong>Molecular Testing (PCR and NGS)</strong><a class="anchor" aria-label="anchor" href="#molecular-testing-pcr-and-ngs"><i class="fas fa-link"></i></a>
</h2>
<p>Molecular testing plays an increasingly important role in the diagnosis, classification, and monitoring of hematologic malignancies</p>
<ul>
<li>
<p><strong>PCR-Based Assays:</strong></p>
<ul>
<li>Used to detect gene mutations and fusion genes that are not visible by cytogenetic analysis</li>
<li>Example: <em>JAK2</em> V617F mutation in MPNs</li>
</ul>
</li>
<li>
<p><strong>Next-Generation Sequencing (NGS):</strong></p>
<ul>
<li>Allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of the genetic landscape of the tumor cells</li>
<li>Used to identify gene mutations, insertions, deletions, and copy number variations</li>
<li>Provides valuable information for diagnosis, prognosis, and treatment planning</li>
</ul>
</li>
</ul>
</div>
<div id="reporting-and-interpretation" class="section level2 unnumbered">
<h2>
<strong>Reporting and Interpretation</strong><a class="anchor" aria-label="anchor" href="#reporting-and-interpretation"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>Karyotype: Describe the karyotype using the ISCN nomenclature and indicate the presence or absence of any chromosomal abnormalities</li>
<li>FISH Results: Report the percentage of cells with the specific chromosomal abnormality</li>
<li>Molecular Testing Results: Report the presence or absence of specific gene mutations or fusion genes</li>
<li>Integrate the Cytogenetic and Molecular Findings with the Patient’s Clinical, Morphologic, and Immunophenotypic Data</li>
<li>Prognostic Interpretation: When reporting results, it’s important to convey the prognostic significance of the findings to the clinician</li>
</ul>
</div>
<div id="key-terms-72" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-72"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Cytogenetic Analysis (Karyotyping):</strong> The study of chromosomes and their abnormalities</li>
<li>
<strong>FISH (Fluorescence In Situ Hybridization):</strong> A technique that uses fluorescent probes to detect specific DNA sequences on chromosomes</li>
<li>
<strong>Molecular Testing:</strong> Techniques to detect gene mutations and fusion genes</li>
<li>
<strong>Mutation:</strong> A change in the DNA sequence of a gene</li>
<li>
<strong>Translocation:</strong> The transfer of genetic material from one chromosome to another</li>
<li>
<strong>Deletion:</strong> The loss of a portion of a chromosome</li>
<li>
<strong>Inversion:</strong> The reversal of a segment of a chromosome</li>
<li>
<strong>Fusion Gene:</strong> A gene formed by the fusion of two separate genes due to a chromosomal translocation or deletion</li>
<li>
<strong>Myeloid Neoplasm:</strong> A hematologic malignancy arising from myeloid progenitor cells</li>
<li>
<strong>Lymphoid Neoplasm:</strong> A hematologic malignancy arising from lymphocytes</li>
<li>
<strong>Leukemia:</strong> A malignant disorder of blood-forming cells</li>
<li>
<strong>Lymphoma:</strong> A malignant disorder of lymphocytes that typically arises in lymph nodes</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="molecularcytogenetic.html">Molecular/Cytogenetic</a></div>
<div class="next"><a href="bcrabl1.html">BCR/ABL1</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#recurring-abnormalities">Recurring Abnormalities</a></li>
<li><a class="nav-link" href="#overview-of-recurring-cytogenetic-abnormalities-in-hematologic-malignancies">Overview of Recurring Cytogenetic Abnormalities in Hematologic Malignancies</a></li>
<li><a class="nav-link" href="#recurring-cytogenetic-abnormalities-by-who-classification">Recurring Cytogenetic Abnormalities by WHO Classification</a></li>
<li><a class="nav-link" href="#myeloid-neoplasms">Myeloid Neoplasms</a></li>
<li><a class="nav-link" href="#lymphoid-neoplasms">Lymphoid Neoplasms</a></li>
<li><a class="nav-link" href="#molecular-testing-pcr-and-ngs">Molecular Testing (PCR and NGS)</a></li>
<li><a class="nav-link" href="#reporting-and-interpretation">Reporting and Interpretation</a></li>
<li><a class="nav-link" href="#key-terms-72">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/main/04-27-laboratory-determinations-molecular-cytogenetic-recurrent.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/edit/main/04-27-laboratory-determinations-molecular-cytogenetic-recurrent.Rmd">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-23 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
